- Email: [email protected]
Ebara installs real-time location management at Futtsu plant
NEWS
Ebara installs real-time location management at Futtsu plant
E
bara Corp has started using Acceliot Inc’s STAR system with RFID technology on the custom pump production line at its Futtsu plant in Japan. The STAR system, which covers an area of approximately 24 000 sq m, uses electromagnetic waves received through 262 antennae installed on pillars inside the facility. RFID (Radio Frequency Identification) tags track components enabling inventory and location management. With the STAR system, Ebara expects to improve real-time location management and visibility of components inside the plant, reduce manpower, improve component search efficiency and increase productivity. The data obtained from the STAR system will be analysed and utilised with a view to deploying the system at other Ebara plants to reduce lead times and enhance manufacturing processes.
For further information, visit www.ebara.co.jp
Covid-19: GormanRupp continues to operate in Ohio
T
he Gorman-Rupp Co will continue to operate all of its locations within the State of Ohio as an essential business during a statewide Stay at Home Order issued in response to the Covid-19 outbreak. Gorman-Rupp says that it intends to continue operating its manufacturing facilities in the State of Ohio during this period, while complying with all applicable laws and will be following the recommendations and guidelines of both local and State government and the Centers for Disease Control.
For further information, visit www.gormanrupp.com
Pentair updates on Covid-19 impact
P
entair plc says it has experienced reduced production in a number
14
Pump Industry Analyst
of key facilities as the result of “shelter in place” orders and suspensions of operations in several facilities due to the Covid-19 pandemic. “This is an unprecedented time, and our focus, like yours, is the health and wellbeing of our employees, our customers, and our communities,” said John Stauch, Pentair president and CEO. “A crisis such as this reminds us that the need for water touches nearly everything we do. No matter who we are or where we live, we are all connected by our reliance on clean, safe water.” “Pentair is in strong financial condition and we believe we are well-positioned to navigate the uncertainty of the current environment,” added Stauch. “We are taking appropriate steps to reduce expenses and manage costs, reduce or defer capital spending, and closely manage our working capital.”
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Subscription Information An annual subscription to Pump Industry Analyst includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received. More information:
For further information, visit www.pentair.com
www.elsevier.com/journals/institutional/pump-industryanalyst/1359-6128
Grundfos to close BioBooster operations
Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: permissions@ elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘Gen eral Information’, then Permissions Query Form’.
T
he Grundfos BioBooster business is to close following a series of unsuccessful attempts to refocus the business. Grundfos says that the company has failed to make a profit since it started in 1999 despite strong technology and significant investments. “We remain dedicated to pioneering solutions for water-related challenges, which is reflected in water solutions being central to our 2025 strategy. However, following a strategic assessment, we have regrettably concluded that a continuation of BioBooster activities would not be feasible. The decision is being made now to prevent further losses and give employees and customers clarity,” said Poul Due Jensen, Grundfos Group EVP, CSO. “Project-oriented businesses like Grundfos BioBooster have an uncertain nature. Winning orders can take years and investments must be made continuously and evaluated in the long term. Patience has been required, and we believe we have given various possible routes a fair chance over the years,” said Tommy Due Høy, Grundfos Group VP, Global Service & Solutions. Service on existing BioBooster wastewater treatment plants will continue as part of Grundfos DK Service.
For further information, visit www.grundfos.com
In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this publication, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid ad vances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) Limited 12979 The content of this newsletter is compiled from a variety of sources including press releases.
March 2020
Ebara installs real-time location management at Futtsu plant
E
bara Corp has started using Acceliot Inc’s STAR system with RFID technology on the custom pump production line at its Futtsu plant in Japan. The STAR system, which covers an area of approximately 24 000 sq m, uses electromagnetic waves received through 262 antennae installed on pillars inside the facility. RFID (Radio Frequency Identification) tags track components enabling inventory and location management. With the STAR system, Ebara expects to improve real-time location management and visibility of components inside the plant, reduce manpower, improve component search efficiency and increase productivity. The data obtained from the STAR system will be analysed and utilised with a view to deploying the system at other Ebara plants to reduce lead times and enhance manufacturing processes.
For further information, visit www.ebara.co.jp
Covid-19: GormanRupp continues to operate in Ohio
T
he Gorman-Rupp Co will continue to operate all of its locations within the State of Ohio as an essential business during a statewide Stay at Home Order issued in response to the Covid-19 outbreak. Gorman-Rupp says that it intends to continue operating its manufacturing facilities in the State of Ohio during this period, while complying with all applicable laws and will be following the recommendations and guidelines of both local and State government and the Centers for Disease Control.
For further information, visit www.gormanrupp.com
Pentair updates on Covid-19 impact
P
entair plc says it has experienced reduced production in a number
14
Pump Industry Analyst
of key facilities as the result of “shelter in place” orders and suspensions of operations in several facilities due to the Covid-19 pandemic. “This is an unprecedented time, and our focus, like yours, is the health and wellbeing of our employees, our customers, and our communities,” said John Stauch, Pentair president and CEO. “A crisis such as this reminds us that the need for water touches nearly everything we do. No matter who we are or where we live, we are all connected by our reliance on clean, safe water.” “Pentair is in strong financial condition and we believe we are well-positioned to navigate the uncertainty of the current environment,” added Stauch. “We are taking appropriate steps to reduce expenses and manage costs, reduce or defer capital spending, and closely manage our working capital.”
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail: [email protected] Production Support Manager: Lin Lucas E-mail: [email protected] Subscription Information An annual subscription to Pump Industry Analyst includes 12 issues and online access for up to 5 users. Subscriptions run for 12 months, from the date payment is received. More information:
For further information, visit www.pentair.com
www.elsevier.com/journals/institutional/pump-industryanalyst/1359-6128
Grundfos to close BioBooster operations
Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: permissions@ elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘Gen eral Information’, then Permissions Query Form’.
T
he Grundfos BioBooster business is to close following a series of unsuccessful attempts to refocus the business. Grundfos says that the company has failed to make a profit since it started in 1999 despite strong technology and significant investments. “We remain dedicated to pioneering solutions for water-related challenges, which is reflected in water solutions being central to our 2025 strategy. However, following a strategic assessment, we have regrettably concluded that a continuation of BioBooster activities would not be feasible. The decision is being made now to prevent further losses and give employees and customers clarity,” said Poul Due Jensen, Grundfos Group EVP, CSO. “Project-oriented businesses like Grundfos BioBooster have an uncertain nature. Winning orders can take years and investments must be made continuously and evaluated in the long term. Patience has been required, and we believe we have given various possible routes a fair chance over the years,” said Tommy Due Høy, Grundfos Group VP, Global Service & Solutions. Service on existing BioBooster wastewater treatment plants will continue as part of Grundfos DK Service.
For further information, visit www.grundfos.com
In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this publication, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid ad vances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Digitally Produced by Mayfield Press (Oxford) Limited 12979 The content of this newsletter is compiled from a variety of sources including press releases.
March 2020